trending Market Intelligence /marketintelligence/en/news-insights/trending/RS--Aoe44W2bhnVeTpBzGA2 content esgSubNav
In This List

Celsion to raise $15M in common stock offering

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Celsion to raise $15M in common stock offering

Celsion Corp. is looking to raise up to $15 million in a common stock offering with Aspire Capital Fund LLC, a Chicago-based investment fund specializing in open market and direct equity investments in public companies.

Under the agreement, Aspire will buy up to 100,000 Celsion common shares per business day within a 24-month period.

In addition, Aspire may increase the number of common shares it will purchase for up to 2 million per business day.

Lawrenceville, N.J.-based Celsion develops and commercializes directed chemotherapy, DNA-mediated immunotherapy and RNA-based therapy products to treat cancer.